Table 2.
Different gene expression values of cancer specific genes between non amplified (NA) and amplified (PA) RNA samples from colorectal carcinoma samples.
| Affy | Gb | Bases | Anotation | Avg. Signals NA | Avg. Signals PA | FC PA/NA | P |
|---|---|---|---|---|---|---|---|
| 221455_s_at | NM_030753 | 56038 | Wingless-type MMTV integration site family, member 3 (WNT3). | 20 | 78 | 4 | .04 |
| 212447_at | AF161402 | 23,589 | HSPC284 mRNA, partial cds. | 2480 | 9611 | 4 | .01 |
| 201111_at | NM_001253 | 50,649 | Brain cellular apoptosis susceptibility protein (CSE1). | 2568 | 7431 | 3 | .01 |
| 209056_s_at | NM_001253 | 62,329 | CDC5 (cell division cycle 5, S. pombe, homolog)-like (CDC5L). | 1399 | 3861 | 3 | .01 |
| 206458_s_at | NM_024494 | 54,746 | Wingless-type MMTV integration site family, member 2B (WNT2B). | 72 | 177 | 2 | .01 |
| 207149_at | L33477 | 1,102,757 | Br-cadherin mRNA, complete cds. | 35 | 84 | 2 | .04 |
| 204731_at | NM_003243 | 225,660 | Transforming growth factor, beta receptor III (TGFBR3). | 602 | 1336 | 2 | .04 |
| 219226_at | NM_016507 | 73,062 | CDC2-related protein kinase 7 (CrkRS). | 555 | 1131 | 2 | .01 |
| 217366_at | Z37994 | 3620 | Alpha E-catenin pseudogene. | 30 | 6 | 2 | .04 |
| 208504_x_at | NM_018931 | 3321 | Protocadherin beta 11 (PCDHB11). | 33 | 11 | 2 | .04 |
| 201069_at | NM_004530 | 27,516 | Matrix metalloproteinase 2 (MMP2). | 1528 | 887 | −2 | .04 |
| 203968_s_at | NM_001254 | 15,268 | Cell division cycle 6 (CDC6). | 624 | 338 | −2 | .01 |
| 203918_at | NM_002587 | 25,296 | Protocadherin 1 (PCDH1). | 544 | 290 | −2 | .04 |
| 208756_at | U36764 | 9235 | TGF-beta receptor interacting protein 1. | 4451 | 2355 | −2 | .01 |
| 210838_s_at | L17075 | 15,944 | TGF-b superfamily receptor type I. | 277 | 127 | −2 | .01 |
| 206943_at | NM_004612 | 49,063 | Transforming growth factor, beta receptor I (TGFBR1). | 331 | 150 | −2 | .01 |
| 212143_s_at | BF340228 | 9028 | Insulin-like growth factor binding protein 3. | 1192 | 462 | −3 | .01 |
| 202039_at | NM_004740 | 2089 | TGFB1-induced antiapoptotic factor 1 (TIAF1). | 1000 | 371 | −3 | .01 |
| 203214_x_at | NM_001786 | 18927 | Cell division cycle 2, G1 to S and G2 to M (CDC2). | 3181 | 1174 | −3 | .01 |
| 160020_at | Z48481 | 11,011 | Membrane-type matrix metalloproteinase 1 (MMP1). | 1258 | 437 | −3 | .01 |
| 217010_s_at | AF277724 | 46,558 | Cell division cycle 25C splice variant 3 (CDC25C). | 211 | 61 | −3 | .01 |
| 204696_s_at | NM_001789 | 31,134 | Cell division cycle 25A (CDC25A). | 123 | 34 | −4 | .01 |
| 203527_s_at | NM_000038 | 108,353 | Adenomatosis polyposis coli (APC). | 85 | 23 | −4 | .01 |
| 210287_s_at | U01134 | 192,877 | Soluble vascular endothelial cell growth factor receptor (sflt). | 143 | 37 | −4 | .01 |
| 203878_s_at | NM_005940 | 11,468 | Matrix metalloproteinase 11 (stromelysin 3) (MMP11). | 1546 | 400 | −4 | .01 |
| 203365_s_at | NM_002428 | 21,524 | Matrix metalloproteinase 15 (membrane-inserted) (MMP15). | 388 | 93 | −4 | .04 |
| 203683_s_at | NM_003377 | 3994 | Vascular endothelial growth factor B (VEGFB). | 422 | 78 | −5 | .01 |
| 217279_x_at | X83535 | 11,011 | Membrane-type matrix Metalloproteinase (MMP14). | 244 | 27 | −9 | .01 |
| 204380_s_at | M58051 | 15,565 | Fibroblast growth factor receptor (FGFR3). | 224 | 25 | −9 | .01 |
| 207334_s_at | NM_003242 | 87,641 | Transforming growth factor, beta receptor II (TGFBR2). | 323 | 15 | −16 | .01 |